viral genome or elements thereof as genetic vector

Industry

CPC
C12N2760/14143

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C12Biochemistry C12NMICRO-ORGANISMS OR ENZYMES COMPOSITIONS THEREOF PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS MUTATION OR GENETIC ENGINEERING CULTURE MEDIA C12N2760/00ssRNA Viruses negative-sense

Current Industry

C12N2760/14143viral genome or elements thereof as genetic vector

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Human ebola virus species and compositions and methods thereof
- Patent number 10,428,314
- Issue date Oct 1, 2019
- The United States of America, as represented by the Secretary, Department of...
- Jonathan S. Towner
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Human Ebola virus species and compositions and methods thereof
- Patent number 9,790,473
- Issue date Oct 17, 2017
- The United States of America, as represented by the Secretary, Department of...
- Jonathan S. Towner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Filovirus vectors and noninfectious filovirus-based particles
- Patent number 8,900,595
- Issue date Dec 2, 2014
- Wisconsin Alumni Research Foundation
- Yoshihiro Kawaoka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Filovirus vectors and noninfectious filovirus-based particles
- Patent number 7,211,378
- Issue date May 1, 2007
- Wisconsin Alumni Research Foundation
- Yoshihiro Kawaoka
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
GENE THERAPIES FOR STARGARDT DISEASE (ABCA4)
- Publication number 20240207450
- Publication date Jun 27, 2024
- University of Massachusetts
- Hemant Khanna
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FILOVIRUS VECTORS AND PARTICLES PRODUCED THEREFROM
- Publication number 20180273588
- Publication date Sep 27, 2018
- WISCONSIN ALUMNI RESEARCH FOUNDATION (WARF)
- Yoshihiro Kawaoka
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HUMAN EBOLA VIRUS SPECIES AND COMPOSITIONS AND METHODS THEREOF
- Publication number 20180002675
- Publication date Jan 4, 2018
- The United States of America, as represented by the Secretary, Department of...
- Jonathan S. Towner
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Human Ebola Virus Species and Compositions and Methods Thereof
- Publication number 20120251502
- Publication date Oct 4, 2012
- The Government of the US as Represented by the Secretary of the Dept. of health
- Jonathan S. Towner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Filovirus vectors and noninfectious filovirus-based particles
- Publication number 20100267116
- Publication date Oct 21, 2010
- WISCONSIN ALUMNI RESEARCH FOUNDATION
- Yoshihiro Kawaoka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FILOVIRUS VECTORS AND NONINFECTIOUS FILOVIRUS-BASED PARTICLES
- Publication number 20100080825
- Publication date Apr 1, 2010
- Wisconsin Alumni Research Foundation
- Yoshihiro Kawaoka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Filovirus vectors and noninfectious Filovirus-based particles
- Publication number 20030215794
- Publication date Nov 20, 2003
- Yoshihiro Kawaoka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

viral genome or elements thereof as genetic vector

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Human ebola virus species and compositions and methods thereof

Human Ebola virus species and compositions and methods thereof

Filovirus vectors and noninfectious filovirus-based particles

Filovirus vectors and noninfectious filovirus-based particles

Patents Applicationslast 30 patents

GENE THERAPIES FOR STARGARDT DISEASE (ABCA4)

FILOVIRUS VECTORS AND PARTICLES PRODUCED THEREFROM

HUMAN EBOLA VIRUS SPECIES AND COMPOSITIONS AND METHODS THEREOF

Human Ebola Virus Species and Compositions and Methods Thereof

Filovirus vectors and noninfectious filovirus-based particles

FILOVIRUS VECTORS AND NONINFECTIOUS FILOVIRUS-BASED PARTICLES

Filovirus vectors and noninfectious Filovirus-based particles